The pertinent amount is not how much MNTA spent on Lovenox development, but rather is how much NVS spent on Lovenox development that is subject to reimbursement by MNTA.
MNTA’s old financial statements are useful for estimating how much NVS spent, but certain assumptions must be made about how the out-of-pocket amounts were split between the two companies during a 7-year period.
In other words, the answer to this question is not a simple look-it-up factoid; if it were, I would have posted the answer already.